Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort

Bálint, Anita, Rutkai, Mariann, Kolar, Martin, Bortlik, Martin, Duricovad, Dana, Hruba, Veronika, Lukas, Milan, Mitrova, Katarina, Malickova, Karin, Lukas, Martin, Szepes, Zoltán, Nagy, Ferenc, Palatka, Károly, Lovas, Szilvia, Végh, Zsuzsanna, Kürti, Zsuzsanna, Csontos, Ágnes Anna, Miheller, Pál, Nyári, Tibor András, Bor, Renáta, Milassin, Ágnes, Fábián, Anna, Szántó, Kata, Lakatos, Péter László, Molnár, Tamás, Farkas, Klaudia: Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.
EXPERT OPINION ON BIOLOGICAL THERAPY, 18 (11). pp. 1181-1187. ISSN 1471-2598 (2018)

[img] Text
Balint_Elfogadott_InfliximabCT-P13therapy.pdf - Published Version
Korlátozott. Registered users only

Download (2MB) | Request a copy
Item Type: Article
Journal or Publication Title: EXPERT OPINION ON BIOLOGICAL THERAPY
Date: 2018
Volume: 18
Number: 11
Page Range: pp. 1181-1187
ISSN: 1471-2598
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: angol
MTMT id: 30320964
DOI id: https://doi.org/10.1080/14712598.2018.1530758
Date Deposited: 2019. May. 13. 13:15
Last Modified: 2019. May. 13. 13:15
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/15419
Web of Science® Times Cited: 4 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year